logo

Strongbridge Biopharma Plc (SBBP)



Trade SBBP now with
  Date
  Headline
8/8/2018 6:39:08 AM Strongbridge Biopharma Q2 Loss Per Share 40.06 Vs Loss $0.86 Last Year
8/8/2018 6:36:39 AM Strongbridge Biopharma Announces Positive Top-Line Results From Pivotal Phase 3 SONICS Study Of RECORLEV
5/10/2018 7:37:18 AM Strongbridge Biopharma Q1 GAPP Loss Per Share $0.66 Vs Loss $0.83 Last Year
4/2/2018 7:33:16 AM Strongbridge Biopharma Doses First Four Patients In LOGICS
3/12/2018 7:35:18 AM Strongbridge Biopharma Q4 Loss Attributable To Holders $18.7 Mln Or $0.47/shr Vs Loss $16.0 Mln Or $0.71/shr Last Year
2/23/2018 7:33:52 AM Strongbridge Biopharma To Hold Its AGM Of Shareholders On May 15, 2018
1/23/2018 4:30:26 PM Strongbridge Biopharma Announces Proposed Public Offering Of 5 Mln Ordinary Shares
1/18/2018 7:33:25 AM Strongbridge Receives Notice Of Allowance From U.S. Patent And Trademark Office For Patent Covering RECORLEV
1/17/2018 7:04:36 AM Aeterna Zentaris Signs Licensing And Assignment Deal With Strongbridge For Macrilen In U.S. And Canada
11/14/2017 7:34:38 AM Strongbridge Biopharma Q3 Net Loss Attributable To Ordinary Shareholders $35.1 Mln Or $0.98 Per Share
10/3/2017 4:04:32 PM Strongbridge Biopharma Announces Proposed Public Offering Of Ordinary Shares
7/17/2017 7:36:47 AM Strongbridge Biopharma Plc Secures $53 Mln Financing From CRG